2DR.F · Inspire Medical Systems, Inc

-

Please sign in to comment on 2DR.F

1 Comment

Admin

4 years, 1 month ago

Inspire Medical Systems, Inc is currently in a long term downtrend where the price is trading 7.5% below its 200 day moving average.

From a valuation standpoint, the stock is 96.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 48.0.

Inspire Medical Systems, Inc's total revenue rose by 71.0% to $46M since the same quarter in the previous year.

Its net income has increased by 17.6% to $-7M since the same quarter in the previous year.

Finally, its free cash flow grew by 27.7% to $-5M since the same quarter in the previous year.

Based on the above factors, Inspire Medical Systems, Inc gets an overall score of 4/5.

ISIN	US4577301090
Sector	Healthcare
Industry	Medical Devices
Exchange	F
CurrencyCode	EUR

Market Cap	4B
PE Ratio	90.2
Target Price	257.9
Beta	1.39
Dividend Yield	None

ABOUT

Inspire Medical Systems, Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

2DR.F · Inspire Medical Systems, Inc

-

Inspire Medical Systems, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Inspire Medical Systems, Inc using a moving average strategy